List of Tables
Table 1. Global Active Hemostatic Agents Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Active Hemostatic Agents Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Active Hemostatic Agents Market Competitive Situation by Manufacturers in 2024
Table 4. Global Active Hemostatic Agents Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Active Hemostatic Agents Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Active Hemostatic Agents Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Active Hemostatic Agents Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Active Hemostatic Agents Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Active Hemostatic Agents, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Active Hemostatic Agents, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Active Hemostatic Agents, Product Type & Application
Table 12. Global Key Manufacturers of Active Hemostatic Agents, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Active Hemostatic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Hemostatic Agents as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Active Hemostatic Agents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Active Hemostatic Agents Sales by Region (2020-2025) & (K Units)
Table 18. Global Active Hemostatic Agents Sales Market Share by Region (2020-2025)
Table 19. Global Active Hemostatic Agents Sales by Region (2026-2031) & (K Units)
Table 20. Global Active Hemostatic Agents Sales Market Share by Region (2026-2031)
Table 21. Global Active Hemostatic Agents Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Active Hemostatic Agents Revenue Market Share by Region (2020-2025)
Table 23. Global Active Hemostatic Agents Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Active Hemostatic Agents Revenue Market Share by Region (2026-2031)
Table 25. North America Active Hemostatic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Active Hemostatic Agents Sales by Country (2020-2025) & (K Units)
Table 27. North America Active Hemostatic Agents Sales by Country (2026-2031) & (K Units)
Table 28. North America Active Hemostatic Agents Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Active Hemostatic Agents Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Active Hemostatic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Active Hemostatic Agents Sales by Country (2020-2025) & (K Units)
Table 32. Europe Active Hemostatic Agents Sales by Country (2026-2031) & (K Units)
Table 33. Europe Active Hemostatic Agents Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Active Hemostatic Agents Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Active Hemostatic Agents Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Active Hemostatic Agents Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Active Hemostatic Agents Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Active Hemostatic Agents Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Active Hemostatic Agents Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Active Hemostatic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Active Hemostatic Agents Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Active Hemostatic Agents Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Active Hemostatic Agents Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Active Hemostatic Agents Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Active Hemostatic Agents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Active Hemostatic Agents Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Active Hemostatic Agents Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Active Hemostatic Agents Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Active Hemostatic Agents Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Active Hemostatic Agents Sales (K Units) by Type (2020-2025)
Table 51. Global Active Hemostatic Agents Sales (K Units) by Type (2026-2031)
Table 52. Global Active Hemostatic Agents Sales Market Share by Type (2020-2025)
Table 53. Global Active Hemostatic Agents Sales Market Share by Type (2026-2031)
Table 54. Global Active Hemostatic Agents Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Active Hemostatic Agents Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Active Hemostatic Agents Revenue Market Share by Type (2020-2025)
Table 57. Global Active Hemostatic Agents Revenue Market Share by Type (2026-2031)
Table 58. Global Active Hemostatic Agents Price (US$/Unit) by Type (2020-2025)
Table 59. Global Active Hemostatic Agents Price (US$/Unit) by Type (2026-2031)
Table 60. Global Active Hemostatic Agents Sales (K Units) by Application (2020-2025)
Table 61. Global Active Hemostatic Agents Sales (K Units) by Application (2026-2031)
Table 62. Global Active Hemostatic Agents Sales Market Share by Application (2020-2025)
Table 63. Global Active Hemostatic Agents Sales Market Share by Application (2026-2031)
Table 64. Global Active Hemostatic Agents Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Active Hemostatic Agents Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Active Hemostatic Agents Revenue Market Share by Application (2020-2025)
Table 67. Global Active Hemostatic Agents Revenue Market Share by Application (2026-2031)
Table 68. Global Active Hemostatic Agents Price (US$/Unit) by Application (2020-2025)
Table 69. Global Active Hemostatic Agents Price (US$/Unit) by Application (2026-2031)
Table 70. Medtronic Plc. Company Information
Table 71. Medtronic Plc. Description and Business Overview
Table 72. Medtronic Plc. Active Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Medtronic Plc. Active Hemostatic Agents Product
Table 74. Medtronic Plc. Recent Developments/Updates
Table 75. Ethicon Inc. Company Information
Table 76. Ethicon Inc. Description and Business Overview
Table 77. Ethicon Inc. Active Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Ethicon Inc. Active Hemostatic Agents Product
Table 79. Ethicon Inc. Recent Developments/Updates
Table 80. Pfizer Inc. Company Information
Table 81. Pfizer Inc. Description and Business Overview
Table 82. Pfizer Inc. Active Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Pfizer Inc. Active Hemostatic Agents Product
Table 84. Pfizer Inc. Recent Developments/Updates
Table 85. Baxter International Inc. Company Information
Table 86. Baxter International Inc. Description and Business Overview
Table 87. Baxter International Inc. Active Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Baxter International Inc. Active Hemostatic Agents Product
Table 89. Baxter International Inc. Recent Developments/Updates
Table 90. CryoLife Inc. Company Information
Table 91. CryoLife Inc. Description and Business Overview
Table 92. CryoLife Inc. Active Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. CryoLife Inc. Active Hemostatic Agents Product
Table 94. CryoLife Inc. Recent Developments/Updates
Table 95. Integra Life Sciences Corporation, etc. Company Information
Table 96. Integra Life Sciences Corporation, etc. Description and Business Overview
Table 97. Integra Life Sciences Corporation, etc. Active Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Integra Life Sciences Corporation, etc. Active Hemostatic Agents Product
Table 99. Integra Life Sciences Corporation, etc. Recent Developments/Updates
Table 100. Stryker Company Information
Table 101. Stryker Description and Business Overview
Table 102. Stryker Active Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Stryker Active Hemostatic Agents Product
Table 104. Stryker Recent Developments/Updates
Table 105. Biom’up Company Information
Table 106. Biom’up Description and Business Overview
Table 107. Biom’up Active Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Biom’up Active Hemostatic Agents Product
Table 109. Biom’up Recent Developments/Updates
Table 110. BD Company Information
Table 111. BD Description and Business Overview
Table 112. BD Active Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. BD Active Hemostatic Agents Product
Table 114. BD Recent Developments/Updates
Table 115. Johnson & Johnson Services Company Information
Table 116. Johnson & Johnson Services Description and Business Overview
Table 117. Johnson & Johnson Services Active Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Johnson & Johnson Services Active Hemostatic Agents Product
Table 119. Johnson & Johnson Services Recent Developments/Updates
Table 120. C.R.Bard Company Information
Table 121. C.R.Bard Description and Business Overview
Table 122. C.R.Bard Active Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. C.R.Bard Active Hemostatic Agents Product
Table 124. C.R.Bard Recent Developments/Updates
Table 125. B. Braun Melsungen AG Company Information
Table 126. B. Braun Melsungen AG Description and Business Overview
Table 127. B. Braun Melsungen AG Active Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. B. Braun Melsungen AG Active Hemostatic Agents Product
Table 129. B. Braun Melsungen AG Recent Developments/Updates
Table 130. Z-Medica LLC Company Information
Table 131. Z-Medica LLC Description and Business Overview
Table 132. Z-Medica LLC Active Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Z-Medica LLC Active Hemostatic Agents Product
Table 134. Z-Medica LLC Recent Developments/Updates
Table 135. Advanced Medical Solutions Group plc Company Information
Table 136. Advanced Medical Solutions Group plc Description and Business Overview
Table 137. Advanced Medical Solutions Group plc Active Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Advanced Medical Solutions Group plc Active Hemostatic Agents Product
Table 139. Advanced Medical Solutions Group plc Recent Developments/Updates
Table 140. GELITA GA Company Information
Table 141. GELITA GA Description and Business Overview
Table 142. GELITA GA Active Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. GELITA GA Active Hemostatic Agents Product
Table 144. GELITA GA Recent Developments/Updates
Table 145. Active Hemostatic Agents Company Information
Table 146. Active Hemostatic Agents Description and Business Overview
Table 147. Active Hemostatic Agents Active Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Active Hemostatic Agents Active Hemostatic Agents Product
Table 149. Active Hemostatic Agents Recent Developments/Updates
Table 150. Warrior Tactical, LLC Company Information
Table 151. Warrior Tactical, LLC Description and Business Overview
Table 152. Warrior Tactical, LLC Active Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Warrior Tactical, LLC Active Hemostatic Agents Product
Table 154. Warrior Tactical, LLC Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Active Hemostatic Agents Distributors List
Table 158. Active Hemostatic Agents Customers List
Table 159. Active Hemostatic Agents Market Trends
Table 160. Active Hemostatic Agents Market Drivers
Table 161. Active Hemostatic Agents Market Challenges
Table 162. Active Hemostatic Agents Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Active Hemostatic Agents
Figure 2. Global Active Hemostatic Agents Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Active Hemostatic Agents Market Share by Type: 2024 & 2031
Figure 4. Thrombin based hemostats Product Picture
Figure 5. Surgical Sealants Product Picture
Figure 6. Combination Products Product Picture
Figure 7. Global Active Hemostatic Agents Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Active Hemostatic Agents Market Share by Application: 2024 & 2031
Figure 9. Hospitals
Figure 10. Ambulatory Surgical Centers
Figure 11. Specialty Clinics
Figure 12. Global Active Hemostatic Agents Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Active Hemostatic Agents Market Size (2020-2031) & (US$ Million)
Figure 14. Global Active Hemostatic Agents Sales (2020-2031) & (K Units)
Figure 15. Global Active Hemostatic Agents Average Price (US$/Unit) & (2020-2031)
Figure 16. Active Hemostatic Agents Report Years Considered
Figure 17. Active Hemostatic Agents Sales Share by Manufacturers in 2024
Figure 18. Global Active Hemostatic Agents Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Active Hemostatic Agents Players: Market Share by Revenue in Active Hemostatic Agents in 2024
Figure 20. Active Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Active Hemostatic Agents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Active Hemostatic Agents Sales Market Share by Country (2020-2031)
Figure 23. North America Active Hemostatic Agents Revenue Market Share by Country (2020-2031)
Figure 24. United States Active Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Active Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Active Hemostatic Agents Sales Market Share by Country (2020-2031)
Figure 27. Europe Active Hemostatic Agents Revenue Market Share by Country (2020-2031)
Figure 28. Germany Active Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Active Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Active Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Active Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Active Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Active Hemostatic Agents Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Active Hemostatic Agents Revenue Market Share by Region (2020-2031)
Figure 35. China Active Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Active Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Active Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Active Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Active Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Active Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Active Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Active Hemostatic Agents Sales Market Share by Country (2020-2031)
Figure 43. Latin America Active Hemostatic Agents Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Active Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Active Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Active Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Active Hemostatic Agents Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Active Hemostatic Agents Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Active Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Active Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Active Hemostatic Agents Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Active Hemostatic Agents by Type (2020-2031)
Figure 53. Global Revenue Market Share of Active Hemostatic Agents by Type (2020-2031)
Figure 54. Global Active Hemostatic Agents Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Active Hemostatic Agents by Application (2020-2031)
Figure 56. Global Revenue Market Share of Active Hemostatic Agents by Application (2020-2031)
Figure 57. Global Active Hemostatic Agents Price (US$/Unit) by Application (2020-2031)
Figure 58. Active Hemostatic Agents Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
